Clinical Trials List
Protocol NumberTSHDM1402
2016-01-01 - 2016-12-31
Others
Terminated1
ICD-10I10
Essential (primary) hypertension
-
Trial Applicant
TSH BIOPHARM CORPORATION LTD.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Taipei Medical University Hospital
Taiwan National PI
劉明哲
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
39 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
46 participants
-
Global
46 participants
